Optometry News

Eclipse Life Sciences has enrolled and dosed the first patient in the BETTIS-1 phase 2 clinical trial investigating the EC-104 implant for the treatment of diabetic macular edema, according to a press release.

Eye6 with Ivy, a new wearable vision aid with an interactive AI visual assistant for individuals with age-related macular degeneration and other retinal disorders, is now available, according to a press release from Eyedaptic.

An AI program accurately identified posterior vitreous opacities in patients with posterior vitreous detachments, which may improve screening for retinal tears, according to a study.

The progression of myopia among school-aged children in China appeared to primarily affect changes in inner retinal thickness over the course of 1 year, according to research.

An AI model was able to identify several common eye diseases in children using cell phone photos that could be taken at home, researchers reported in JAMA Pediatrics.

The FDA approved the Enzeevu 2 mg vial kit and prefilled syringe for intravitreal injection for the treatment of neovascular age-related macular degeneration, according to a press release from Sandoz.

Eyenovia and SGN Nanopharma have announced a collaboration agreement to develop a new drug-device combination product for chronic dry eye disease.

When managing myopic traction maculopathy, the timing of surgery should be carefully evaluated, avoiding early or delayed intervention, according to a speaker at the American Society of Retina Specialists annual meeting.

As your paycheck grows, so does your discretionary spending and saving. While it is easy to spend, it is not always clear where to invest your next dollar intended for future spending.

In this Healio Video Perspective from the ASRS meeting, Michael A. Singer, MD, of the University of Texas Health Science Center in San Antonio, discusses topline results for MCO-010 for the treatment of retinitis pigmentosa.